Literature DB >> 29594975

Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.

Danny J Avalos1, Antonio Mendoza-Ladd2, Marc J Zuckerman2, Mohammad Bashashati2, Andres Alvarado3, Alok Dwivedi3, Oriana M Damas4.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is a devastating immune-mediated disease on the rise in Hispanics living in the USA. Prior observational studies comparing IBD characteristics between Hispanics and non-Hispanic whites (NHW) have yielded mixed results. AIMS: We performed a meta-analysis of observational studies examining IBD phenotype in Hispanics compared to NHW.
METHODS: We conducted a systematic search of US-based studies comparing IBD subtype (Ulcerative Colitis: UC or Crohn's disease: CD) and phenotype (disease location and behavior) between Hispanics and NHW. We evaluated differences in age at IBD diagnosis, the presence of family history and smoking history. A random effects model was chosen "a priori." Categorical and continuous variables were analyzed using odds ratio (OR) or standard mean difference (SMD), respectively.
RESULTS: Seven studies were included with 687 Hispanics and 1586 NHW. UC was more common in Hispanics compared to NHW (OR 2.07, CI 1.13-3.79, p = 0.02). Location of disease was similar between Hispanics and NHW except for the presence of upper gastrointestinal CD, which was less common in Hispanics (OR 0.58, CI 0.32-1.06, p = 0.07). Hispanics were less likely to smoke (OR 0.48, CI 0.26-0.89, p = 0.02) or have a family history of IBD (OR 0.35, CI 0.22-0.55, p < 0.001). CD behavior classified by Montreal classification and age at IBD diagnosis were similar between Hispanics and NHW.
CONCLUSION: UC was more common among US Hispanics compared to NHW. Age at IBD diagnosis is similar for both Hispanics and NHW. For CD, disease behavior is similar, but Hispanics show a trend for less upper gastrointestinal involvement. A family history of IBD and smoking history were less common in Hispanics.

Entities:  

Keywords:  Hispanic Americans; Inflammatory bowel diseases; Minority groups; Phenotype

Mesh:

Year:  2018        PMID: 29594975     DOI: 10.1007/s10620-018-5022-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States.

Authors:  Geoffrey C Nguyen; Christopher A Chong; Rachel Y Chong
Journal:  J Crohns Colitis       Date:  2013-09-24       Impact factor: 9.071

2.  Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.

Authors:  Raina Shivashankar; William J Tremaine; W Scott Harmsen; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-14       Impact factor: 11.382

Review 3.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

4.  Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015.

Authors:  James M Dahlhamer; Emily P Zammitti; Brian W Ward; Anne G Wheaton; Janet B Croft
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-10-28       Impact factor: 17.586

5.  Doctors' experience of coordination across care levels and associated factors. A cross-sectional study in public healthcare networks of six Latin American countries.

Authors:  María-Luisa Vázquez; Ingrid Vargas; Irene Garcia-Subirats; Jean-Pierre Unger; Pierre De Paepe; Amparo Susana Mogollón-Pérez; Isabella Samico; Pamela Eguiguren; Angelica-Ivonne Cisneros; Adriana Huerta; María-Cecilia Muruaga; Fernando Bertolotto
Journal:  Soc Sci Med       Date:  2017-04-03       Impact factor: 4.634

6.  Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians.

Authors:  Jason Hou; Hashem El-Serag; Joseph Sellin; Selvi Thirumurthi
Journal:  Dig Dis Sci       Date:  2011-03-11       Impact factor: 3.199

7.  Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study.

Authors:  Oriana M Damas; Darius A Jahann; Robert Reznik; Jacob L McCauley; Leonardo Tamariz; Amar R Deshpande; Maria T Abreu; Daniel A Sussman
Journal:  Am J Gastroenterol       Date:  2012-12-18       Impact factor: 10.864

8.  Race and inflammatory bowel disease in an urban healthcare system.

Authors:  Justin L Sewell; John M Inadomi; Hal F Yee
Journal:  Dig Dis Sci       Date:  2010-10-09       Impact factor: 3.199

9.  Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.

Authors:  Daniela Simian; Daniela Fluxá; Lilian Flores; Jaime Lubascher; Patricio Ibáñez; Carolina Figueroa; Udo Kronberg; Raúl Acuña; Mauricio Moreno; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

10.  Inequities in access to health care in different health systems: a study in municipalities of central Colombia and north-eastern Brazil.

Authors:  Irene Garcia-Subirats; Ingrid Vargas; Amparo Susana Mogollón-Pérez; Pierre De Paepe; Maria Rejane Ferreira da Silva; Jean Pierre Unger; Carme Borrell; Maria Luisa Vázquez
Journal:  Int J Equity Health       Date:  2014-01-31
View more
  3 in total

1.  Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease.

Authors:  Oriana M Damas; Derek Estes; Danny Avalos; Maria A Quintero; Diana Morillo; Francia Caraballo; Johanna Lopez; Amar R Deshpande; David Kerman; Jacob L McCauley; Ana Palacio; Maria T Abreu; Seth J Schwartz
Journal:  Dig Dis Sci       Date:  2018-07-07       Impact factor: 3.199

2.  Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.

Authors:  Ana Gutiérrez; Pedro Zapater; Elena Ricart; María González-Vivó; Jordi Gordillo; David Olivares; Isabel Vera; Míriam Mañosa; Javier P Gisbert; Mariam Aguas; Eugenia Sánchez-Rodríguez; Maia Bosca-Watts; Viviana Laredo; Blau Camps; Ignacio Marín-Jiménez; Yamile Zabana; María Dolores Martín-Arranz; Roser Muñoz; Mercè Navarro; Eva Sierra; Lucía Madero; Milagros Vela; José Lázaro Pérez-Calle; Empar Sainz; Xavier Calvet; Lara Arias; Victor Morales; Fernando Bermejo; Luis Fernández-Salazar; Manuel Van Domselaar; Luisa De Castro; Cristina Rodríguez; Carmen Muñoz-Villafranca; Rufo Lorente; Montserrat Rivero; Eva Iglesias; Belén Herreros; David Busquets; Joan Riera; María Pilar Martínez-Montiel; Marta Roldón; Oscar Roncero; Esther Hinojosa; Mónica Sierra; Jesús Barrio; Ruth De Francisco; José Huguet; Olga Merino; Daniel Carpio; Daniel Ginard; Fernando Muñoz; Marta Piqueras; Pedro Almela; Federico Argüelles-Arias; Guillermo Alcaín; Luis Bujanda; Noemí Manceñido; Alfredo J Lucendo; Pilar Varela; Iago Rodríguez-Lago; Laura Ramos; Laura Sempere; Eva Sesé; Manuel Barreiro-de Acosta; Eugeni Domènech; Rubén Francés
Journal:  Front Med (Lausanne)       Date:  2022-02-01

Review 3.  Food as Treatment of Inflammatory Bowel Diseases.

Authors:  Ana Maldonado-Contreras
Journal:  Infect Immun       Date:  2022-05-11       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.